These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1422905)

  • 1. The Non Obese Diabetic (NOD) mouse, as a model of T cell mediated autoimmune disease.
    Bach JF
    C R Acad Sci III; 1992; 314(9 Suppl):45-6. PubMed ID: 1422905
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H; Formby B
    Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A defect in central tolerance in NOD mice.
    Kishimoto H; Sprent J
    Nat Immunol; 2001 Nov; 2(11):1025-31. PubMed ID: 11668341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin-dependent diabetes, an autoimmune disease].
    Hamburger J
    C R Acad Sci III; 1986; 303(8):299-301. PubMed ID: 3094847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective role of gamma delta T cells in primary infection with Listeria monocytogenes in autoimmune non-obese diabetic mice.
    Usami J; Hiromatsu K; Matsumoto Y; Maeda K; Inagaki H; Suzuki T; Yoshikai Y
    Immunology; 1995 Oct; 86(2):199-205. PubMed ID: 7490118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.
    Srinivasan S; Bolick DT; Lukashev D; Lappas C; Sitkovsky M; Lynch KR; Hedrick CC
    Diabetes; 2008 Feb; 57(2):484-93. PubMed ID: 18003758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development.
    O'Keeffe M; Brodnicki TC; Fancke B; Vremec D; Morahan G; Maraskovsky E; Steptoe R; Harrison LC; Shortman K
    Int Immunol; 2005 Mar; 17(3):307-14. PubMed ID: 15684037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes.
    Balasa B; Van Gunst K; Sarvetnick N
    Clin Immunol; 2000 May; 95(2):93-8. PubMed ID: 10779402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
    Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
    J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
    Wang J; Yoshida T; Nakaki F; Hiai H; Okazaki T; Honjo T
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11823-8. PubMed ID: 16087865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model.
    Hung JT; Liao JH; Lin YC; Chang HY; Wu SF; Chang TH; Kung JT; Hsieh SL; McDevitt H; Sytwu HK
    J Autoimmun; 2005 Nov; 25(3):181-92. PubMed ID: 16263243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of autoimmune type I diabetes by CD4+ suppressor T cells in superantigen-treated non-obese diabetic mice.
    Kawamura T; Nagata M; Utsugi T; Yoon JW
    J Immunol; 1993 Oct; 151(8):4362-70. PubMed ID: 8409408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
    Jarpe AJ; Hickman MR; Anderson JT; Winter WE; Peck AB
    Reg Immunol; 1990-1991; 3(6):305-17. PubMed ID: 2132756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 12 and autoimmune diabetes.
    Adorini L
    Nat Genet; 2001 Feb; 27(2):131-2. PubMed ID: 11175771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.